Clinical Trials Research

DISA Vascular Set to Start Stellium I Clinical Trial

Published in Biotech Business Week, March 19th, 2007

DISA Vascular's Stellium I Clinical Trial is currently being reviewed by the South African Regulatory Authority (MCC) and the local Independent Ethics Review Boards. A decision is expected by April and the patient enrolment is scheduled to start in May 2007.

The local investigator's meeting is taking place at the luxurious Twelve Apostles Hotel and Spa on the Atlantic Seaboard from 20-21 April. All trial investigators will meet to discuss the finer aspects of the trial in preparation for the trial starting in May..

Keywords: Clinical Trials Research, DISA Vascular.

This article was prepared by Biotech Business Week editors from...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Source: Biotech Business Week (2007-03-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry